These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31089838)

  • 1. Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection.
    Lange A; Cajander S; Magnuson A; Sundén-Cullberg J; Strålin K; Hultgren O
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1425-1434. PubMed ID: 31089838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptide plasma concentrations in patients with community-acquired pneumonia.
    Jendeberg AL; Strålin K; Hultgren O
    Scand J Infect Dis; 2013 Jun; 45(6):432-7. PubMed ID: 23317166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection.
    Cajander S; Rasmussen G; Tina E; Magnuson A; Söderquist B; Källman J; Strålin K
    PLoS One; 2018; 13(2):e0192883. PubMed ID: 29466395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.
    Grobmyer SR; Barie PS; Nathan CF; Fuortes M; Lin E; Lowry SF; Wright CD; Weyant MJ; Hydo L; Reeves F; Shiloh MU; Ding A
    Crit Care Med; 2000 May; 28(5):1276-82. PubMed ID: 10834665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma secretory leukocyte protease inhibitor in febrile patients.
    Duits LA; Tjabringa GS; Aarts NJ; van't Wout JW; Hiemstra PS; Nibbering PH; van Dissel JT
    Clin Microbiol Infect; 2003 Jul; 9(7):605-13. PubMed ID: 12925099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study.
    Mehl A; Åsvold BO; Lydersen S; Paulsen J; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Mar; 17(1):205. PubMed ID: 28284196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.
    Yan ST; Sun LC; Jia HB; Gao W; Yang JP; Zhang GQ
    Am J Emerg Med; 2017 Apr; 35(4):579-583. PubMed ID: 27979420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
    BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.
    Rahman S; Pierce Campbell CM; Torres BN; O'Keefe MT; Ingles DJ; Villa LL; Carvalho da Silva RJ; Cintra RC; Lazcano-Ponce E; Salmeron J; Quiterio M; Giuliano AR
    Oral Dis; 2016 Nov; 22(8):781-790. PubMed ID: 27470907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of community-onset bloodstream infection: a population-based assessment.
    Laupland KB; Gregson DB; Flemons WW; Hawkins D; Ross T; Church DL
    Epidemiol Infect; 2007 Aug; 135(6):1037-42. PubMed ID: 17156500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases.
    Wex T; Sokic-Milutinovic A; Todorovic V; Bjelovic M; Milosavljevic T; Pesko P; Malfertheiner P
    Dig Dis; 2004; 22(4):390-5. PubMed ID: 15812165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.
    Dat VQ; Vu HN; Nguyen The H; Nguyen HT; Hoang LB; Vu Tien Viet D; Bui CL; Van Nguyen K; Nguyen TV; Trinh DT; Torre A; van Doorn HR; Nadjm B; Wertheim HFL
    BMC Infect Dis; 2017 Jul; 17(1):493. PubMed ID: 28701159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    Mod Rheumatol; 2012 Aug; 22(4):576-83. PubMed ID: 22075605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.
    Stępień T; Brożyna M; Kuzdak K; Motylewska E; Komorowski J; Stępień H; Ławnicka H
    Dis Markers; 2017; 2017():4962137. PubMed ID: 28255192
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alarm antiproteases in systemic sclerosis patients.
    Olewicz-Gawlik A; Trzybulska D; Graniczna K; Kuznar-Kaminska B; Katulska K; Batura-Gabryel H; Frydrychowicz M; Danczak-Pazdrowska A; Mozer-Lisewska I
    Hum Immunol; 2017 Sep; 78(9):559-564. PubMed ID: 28606626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alarm secretory leukocyte protease inhibitor increases with progressive metabolic dysfunction.
    López-Bermejo A; Ortega FJ; Castro A; Ricart W; Fernández-Real JM
    Clin Chim Acta; 2011 May; 412(11-12):1122-6. PubMed ID: 21377455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.